Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6957b1f01063d98b1e8f2f17", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Opipramol Dihydrochloride 100 mg", "description": "OPIRAPROL 100, featuring Opipramol Dihydrochloride 100 mg, stands out as a reliable medication from Steris Healthcare Pvt Ltd designed to address anxiety disorders and related somatic issues. This tricyclic compound offers targeted relief by modulating brain chemicals for better emotional balance. Patients often find it helps restore daily functionality without the heavier sedation of some alternatives.\n​\n\nProduct Overview\nOPIRAPROL 100 contains 100 mg of Opipramol Dihydrochloride per tablet, a dibenzazepine derivative primarily classified as an anxiolytic with antidepressant properties. Manufactured by Steris Healthcare Pvt Ltd, it targets generalized anxiety disorder (GAD) and somatoform disorders, where physical symptoms like unexplained pain or fatigue stem from psychological stress. Unlike typical antidepressants that focus solely on serotonin reuptake, Opipramol acts as a sigma-1 receptor agonist, influencing calcium signaling and neurotransmitter release for a calming effect.\n​\n\nThe formulation ensures steady absorption, making it suitable for adults needing moderate to higher dosing. Each pack typically includes 10 tablets, priced accessibly for ongoing therapy under medical supervision. Steris emphasizes quality with WHO-GMP certification, positioning OPIRAPROL 100 as a trusted option in India's mental health market.\n​\n\nHow It Works\nOpipramol Dihydrochloride in OPIRAPROL 100 primarily binds to sigma receptors in the brain, promoting translocation to cell membranes and enhancing neurotransmitter modulation, especially serotonin and dopamine. This biphasic action first reduces acute tension and insomnia, then stabilizes mood over time by downregulating sigma-2 sites during chronic use.\n​\n\nIt also exhibits mild antihistamine and anticholinergic effects, contributing to its sedative properties without strong reuptake inhibition like classic tricyclics. By calming overactive neural pathways, it alleviates the cycle of worry and physical unease, allowing clearer thinking and restful sleep. Clinical studies highlight its efficacy in somatoform cases, where patients fixate on bodily sensations amplified by anxiety.\n​\n\nKey Uses\nHealthcare providers prescribe OPIRAPROL 100 for several interconnected conditions rooted in anxiety.\n\nGeneralized anxiety disorder, easing excessive worry, restlessness, and irritability that disrupt work and relationships.\n​\n\nSomatoform disturbances target fatigue, pain, or gastrointestinal issues without clear organic cause.\n​\n\nMild depressive episodes with prominent anxiety, supporting mood without full antidepressant escalation.\n​\n\nAdjunctive therapy for sleep bruxism or insomnia linked to stress, based on emerging evidence.\n​\n\nIn practice, it suits patients in high-stress environments, like urban professionals in Jaipur facing daily pressures, helping them regain focus and productivity.\n​\n\nKey Benefits\nUsers of OPIRAPROL 100 report transformative effects that extend beyond symptom relief.\n\nRapid anxiety reduction promotes mental clarity, enabling better concentration and decision-making in daily tasks.\n​\n\nMood stabilization balances emotional swings, fostering stronger interpersonal connections and resilience.\n​\n\nEnhanced sleep quality combats insomnia, leading to refreshed mornings and sustained energy.\n​\n\nImproved daily functioning boosts productivity, which is vital for professionals balancing career and personal life.\n​\n\nLower sedation profile compared to benzodiazepines allows safe use during daytime hours.\n​\n\nLong-term, it enhances quality of life by breaking anxiety cycles, with many patients noting fewer somatic complaints after consistent use.\n​\n\nDosage Guidelines\nTake OPIRAPROL 100 as directed, typically 100 mg once or twice daily for adults, swallowed whole with water, with or without food. Start low to assess tolerance, adjusting up to 300 mg daily for severe cases under supervision.\n​\n\nFor children over 6, dosing follows 3 mg/kg body weight, but adult use predominates. Maintain consistent timing to stabilize blood levels, and taper gradually to avoid withdrawal. Missed doses should resume normally without doubling.\n\nPotential Side Effects\nMost side effects of OPIRAPROL 100 are mild and diminish with time, but monitoring remains essential.\n\nCommon ones (1-10%) include dry mouth, nasal congestion, fatigue, dizziness, and orthostatic hypotension, often resolving as the body adjusts.\n\nOccasional (0.1-1%) effects encompass constipation, weight gain, tremor, blurred vision, tachycardia, and mild liver enzyme elevation.\nRare issues (<0.1%) like allergic rashes, urinary retention, confusion, or leukopenia require immediate medical attention, especially in elderly patients or those with heart conditions.\n​\nPrecautions\nAvoid OPIRAPROL 100 in acute glaucoma, urinary retention, ileus, or uncontrolled epilepsy due to anticholinergic risks.\n​\nPregnant or lactating women need doctor approval, as safety data limits use. Steer clear of alcohol and CNS depressants to prevent amplified drowsiness.\n\nMonitor heart rhythm in bradycardia patients and liver function during prolonged therapy. Abrupt stops can trigger rebound anxiety.\nWhen to Consult a Doctor\nSeek prompt advice if side effects intensify, mood worsens paradoxically, or new symptoms like chest pain emerge. Regular check-ins ensure optimal dosing, particularly for those on interacting meds like MAOIs.\n​\nConclusion\nOPIRAPROL 100 with Opipramol Dihydrochloride 100 mg delivers effective, balanced relief for anxiety and somatic disorders, empowering users toward calmer, more productive lives. Backed by Steris Healthcare's commitment to quality, it bridges the gap between symptom management and holistic well-being when used responsibly. Always prioritize professional guidance to maximize benefits while minimizing risks.\n", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2259, "imageuri": "https://productimages.withfloats.com/actual/6957b22c6b1ead52de1e2df4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6957b22c6b1ead52de1e2df4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-02T11:54:24.869Z", "updatedon": "2026-03-13T07:53:58.661Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/opipramol-dihydrochloride-100-mg/2259", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OPIRAPROL 100", "category": "NEUROLOGYRANGE", "tags": [ "opipramol dihydrochloride.", "opipramol dihydrochloride tablets uses.", "opipramol dihydrochloride tablets uses in hindi.", "opipramol dihydrochloride tablets.", "opipramol dihydrochloride uses.", "opipramol dihydrochloride side effects", "opipramol dihydrochloride tablet.", "what is opipramol dihydrochloride.", "side effects of opipramol dihydrochloride.", "opipramol dihydrochloride dosage.", "opipramol dihydrochloride tablet for anxiety disorder", "medicine for generalized anxiety disorder treatment", "tablet for anxiety and stress management", "medication for nervous tension and anxiety", "how opipramol dihydrochloride works for anxiety", "opipramol vs amitriptyline for anxiety", "medicines for stress and anxiety relief", "opipramol dihydrochloride tablets supplier india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e4df2bed1f08484d7249", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 160 mg Tablet", "description": "ENZULAMIDE 160\nEnzalutamide 160mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, specifically designed to inhibit androgen receptor signaling at multiple levels, slowing cancer progression even in castration-resistant cases. This oral medication, typically taken as a single daily 160mg dose (four 40mg capsules), binds directly to the androgen receptor, preventing nuclear translocation and DNA binding, which starves hormone-dependent prostate tumors of growth signals. Patients with metastatic castration-resistant prostate cancer (mCRPC), non-metastatic CRPC (nmCRPC), or metastatic castration-sensitive prostate cancer (mCSPC) benefit from its ability to delay disease advancement, reduce PSA levels, and extend progression-free survival.​\n\nAdministered continuously without cycling, enzalutamide 160mg maintains steady-state plasma levels for consistent anti-tumor activity, making it suitable for long-term management alongside standard care. Its role expands beyond initial hormone therapy failures, offering hope where traditional options falter.​\n\nProduct Uses: Targeting Advanced Prostate Cancer\nEnzalutamide 160mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) post-chemotherapy or in pre-chemo settings, where tumors grow despite low testosterone. It excels in non-metastatic CRPC (nmCRPC) by delaying metastasis onset, with trials showing median metastasis-free survival exceeding 3 years versus placebo. In mCSPC, combination with ADT prolongs overall survival by months, reducing radiographic progression risks.​\n\nClinicians prescribe it for high-risk patients with rising PSA despite androgen deprivation therapy (ADT), as it shrinks tumors, alleviates bone pain from metastases, and improves quality of life metrics like urinary function and fatigue scores. Regular monitoring via PSA doubling time and imaging guides ongoing use.​\n\nKey Benefits of Enzalutamide 160mg\nEnzalutamide 160mg delivers transformative outcomes through potent androgen blockade:\n\nExtended Progression-Free Survival: PROSPER trial data indicate 97% risk reduction in metastasis or death for nmCRPC; ENZAMET shows 33% overall survival benefit in mCSPC.​\n\nPSA Response Rates: Over 78% achieve ≥50% PSA decline in mCRPC, correlating with radiographic stability and symptom palliation.​\n\nBone Metastasis Control: Lowers skeletal-related events by 30-40%, preserving mobility and reducing fracture incidence when paired with bone agents.​\n\nQuality of Life Preservation: FACT-P scores improve in pain, appetite, and emotional well-being domains, enabling patients to maintain daily activities longer.​\n\nOral Convenience: Once-daily dosing without food restrictions enhances adherence compared to infusions or multi-pill regimens.​\n\nThese advantages position enzalutamide 160mg as a cornerstone in modern prostate cancer protocols, particularly for fit patients tolerating its profile.​\n\nSide Effects: Managing Risks Effectively\nWhile effective, enzalutamide 160mg carries side effects from androgen suppression and receptor antagonism, affecting 70-90% of users to varying degrees. Most prove manageable with supportive care, dose holds, or adjustments, but vigilance remains essential.​\n\nCommon Side Effects\nFrequently reported (≥10%) issues include:\n\nFatigue/Asthenia (30-40%): Profound tiredness impacting daily tasks; rest, exercise, and stimulants like modafinil help.​\n\nHot Flashes (20-25%): Sudden heat waves; cooling strategies and SSRIs alleviate symptoms.​\n\nMusculoskeletal Pain (15-30%): Joint/muscle aches; NSAIDs or physical therapy provide relief.​\n\nDiarrhea/Constipation (10-20%): Alternating bowel changes; fiber, hydration, and laxatives balance gut function.​\n\nHypertension (10-15%): Blood pressure elevations; routine monitoring and antihypertensives control spikes.​\n\nThese transient effects often peak in first months, diminishing with acclimation.​\n\nSerious Side Effects\nSeek immediate care for:\n\nSeizures (1-2%): Risk higher with brain history; anticonvulsants or discontinuation advised.​\n\nFalls/Fractures (10-15%): Due to weakness, dizziness; fall precautions and bone density scans mitigate.​\n\nCardiovascular Events: Myocardial infarction, strokes (2-5%); lipid/BP checks essential.​\n\nPosterior Reversible Encephalopathy Syndrome (PRES): Rare confusion, seizures, vision loss; MRI confirms.​\n\nSevere Skin Reactions: Stevens-Johnson syndrome; rash monitoring critical.​\n\nBaseline neurological assessments and quarterly labs optimize safety.​\n\nDosage and Administration Guidelines\nSwallow four 40mg capsules whole once daily at the same time, with or without food, totaling 160mg. No dose reductions below 120mg recommended; hold for grade 3-4 toxicity, resuming at prior dose once resolved. Hepatic impairment (Child-Pugh B/C) warrants caution; renal adjustments unnecessary. Continue indefinitely unless progression or intolerance occurs.​\n\nPrecautions and Monitoring\nAvoid in seizure history without prophylaxis; women (especially pregnant) must not handle due to teratogenicity. Strong CYP2A4 inducers/inhibitors alter exposure—adjust accordingly. Elderly patients face amplified fall risks; annual DEXA scans track bone health. Regular PSA, testosterone, CBC, liver enzymes, and ECGs ensure proactive management.​\n\nConclusion\nEnzalutamide 160mg stands as a pivotal advancement in prostate cancer care, offering substantial delays in disease progression, symptom control, and survival gains for patients facing hormone-resistant stages. By meticulously balancing its robust benefits against manageable side effects through vigilant monitoring and supportive measures, individuals regain control over their health journey. Consult oncologists to integrate this therapy seamlessly, tailoring it to personal profiles for optimal, life-extending results\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n", "price": 5531.0, "discountamount": 1660.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "mCRPC", "growth", "doctor", "Dosage", "action", "fatigue", "product", "WhatsApp", "patients", "androgens", "ENZULAMIDE", "hot flashes", "information", "Enzalutamide", "sterisonline", "sterispharma", "cancer cells", "hypertension", "male hormones", "administration", "health condition", "Common side effects", "comprehensive advice", "healthcare professional", "potent anti-androgen medication", "metastatic castration-resistant prostate cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1528, "imageuri": "https://productimages.withfloats.com/actual/667d2980c303c6d6ad1360bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2980c303c6d6ad1360bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:45:51.202Z", "updatedon": "2026-03-12T07:58:25.307Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-160-mg-tablet/1528", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 160", "category": "Oncology", "tags": [ "enzalutamide 160 mg price in india", "enzalutamide 160 mg uses", "", "enzalutamide 160 mg side effects", "prostate cancer", "prostate tumors of growth signals", "metastatic castration-resistant prostate cancer", "enzalutamide 160 mg tablet uses", "enzalutamide 160 mg tablet dosage", "enzalutamide 160 mg tablet price in india", "enzalutamide 160 mg tablet composition", "enzalutamide 160 mg tablet benefits", "enzalutamide 160 mg tablet side effects", "enzalutamide 160 mg tablet how it works", "enzalutamide 160 mg tablet mechanism of action", "enzalutamide tablets 160 mg information", "enzalutamide 160 mg tablet cost", "enzalutamide 160 mg tablet supplier india", "enzalutamide 160 mg tablet manufacturer", "enzalutamide 160 mg tablet wholesale price", "enzalutamide 160 mg tablet availability in india", "what is enzalutamide 160 mg tablet", "enzalutamide 160 mg tablet treatment use", "enzalutamide 160 mg tablet precautions", "enzalutamide 160 mg tablet alternatives", "enzalutamide 160 mg tablet substitute", "enzalutamide 160 mg tablet india", "enzalutamide 160 mg tablet near me", "enzalutamide 160 mg tablet online india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e3b87247ae19c482b97c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 40mg", "description": "Enzalutamide 40 mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, particularly in metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). This second-generation androgen receptor inhibitor works by disrupting multiple steps in the androgen signaling pathway, offering patients a chance to slow disease progression, reduce tumor burden, and extend survival even after other treatments fail. Administered as a once-daily oral capsule, enzalutamide 40 mg provides four capsules per day (total 160 mg), making it convenient for long-term use in clinical settings where hormone therapy alone proves insufficient.​\n\nPatients often turn to enzalutamide when facing rising PSA levels despite androgen deprivation therapy (ADT), experiencing bone pain, or dealing with cancer spread to lymph nodes or distant sites. Its high affinity for androgen receptors—5-8 times stronger than first-generation antiandrogens like bicalutamide—ensures potent blockade without agonist activity, translating to real-world benefits like delayed chemotherapy needs and improved quality of life during treatment.​\n\nProduct Use and Indications\nEnzalutamide 40 mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with docetaxel or progressing despite ADT. The FDA and EMA approvals extend to non-metastatic CRPC (nmCRPC) with high-risk biochemical recurrence and metastatic castration-sensitive prostate cancer (mCSPC) alongside ADT, based on landmark trials like AFFIRM, PREVAIL, PROSPER, and ARCHES.​\n\nKey uses include:\n\nSlowing tumor growth in hormone-refractory stages by inhibiting androgen-driven proliferation.\n\nReducing skeletal-related events like fractures or spinal cord compression in bone metastases.\n\nDelaying progression to chemotherapy in pre-chemotherapy mCRPC, with PREVAIL showing 17-month median radiographic progression-free survival (rPFS) versus 4 months for placebo.​\n\nIn mCSPC, ARCHES trial data demonstrated 61% risk reduction in progression or death when combined with ADT. Clinicians monitor PSA response (≥50% decline in 70-80% of patients) and imaging every 3 months to assess efficacy.​\n\nMechanism of Action\nEnzalutamide 40 mg exerts a threefold blockade on androgen receptor (AR) signaling: it competitively inhibits androgen binding to AR (with affinity rivaling dihydrotestosterone), prevents nuclear translocation of the ligand-receptor complex, and disrupts DNA binding and coactivator recruitment at androgen response elements. This comprehensive inhibition downregulates oncogenes like TMPRSS2-ERG fusion genes common in prostate cancer, inducing apoptosis and halting cell proliferation without lowering systemic testosterone levels.​\n\nUnlike earlier antiandrogens, enzalutamide avoids partial agonist effects, ensuring pure antagonism even in AR-overexpressing tumors. Its active metabolite, N-desmethyl enzalutamide (via CYP2C8), contributes 30% to activity, with steady-state levels achieved in 4 weeks.​\n\nKey Benefits\nExtended Progression-Free Survival: In PREVAIL (pre-chemo mCRPC), median overall survival reached 32.4 months versus 30.2 for placebo; PROSPER (nmCRPC) delayed metastasis by 22 months.​\n\nPSA Response and Tumor Shrinkage: 78% PSA90 response rate; radiographic responses in 29% with measurable disease.​\n\nQuality of Life Preservation: Delays pain progression (hazard ratio 0.40) and chemotherapy (by 17 months), maintaining daily function.​\n\nBone Protection: Reduces fractures by 30% in high-risk patients via AR inhibition in osteoblasts.​\n\nCombination Synergy: Enhances ADT efficacy in mCSPC, cutting death risk by 33% per ARCHES.​\n\nThese benefits position enzalutamide 40 mg as a cornerstone in modern prostate cancer protocols, especially for fit patients tolerating oral therapy.​\n\nSide Effects\nEnzalutamide 40 mg carries a manageable profile, with most effects dose-related and reversible upon discontinuation.\n\nCommon Side Effects\nFatigue/Asthenia (34-50%): Often mild, peaking in first months; rest and nutrition help.\n\nArthralgia/Myalgia (14-21%): Joint/muscle pain managed with NSAIDs.\n\nHot Flashes (20%): Androgen blockade mimic; hydration aids.\n\nHeadache/Dizziness (12-19%): Transient; avoid driving if severe.\n\nHypertension (6-13%): Monitor BP monthly; antihypertensives as needed.\n\nGI Issues (diarrhea 12%, nausea 11%): Antiemetics support compliance.​\n\nSerious Side Effects\nSeizures (0.9%): Highest risk in epileptics or brain mets; EEG baseline, avoid triggers.\n\nPosterior Reversible Encephalopathy (PRES): Rare (<0.1%); headache, confusion—MRI confirms.\n\nFalls/Fractures (15% increased risk): Due to weakness/falls; DEXA scans recommended.\n\nCardiac Events (2-5%): MI/arrhythmias; ECG monitoring in CVD history.\n\nHepatic Injury (1%): ALT/AST elevation; monthly labs first 3 months.​\n\nDiscontinuation occurs in 8-10%; supportive care mitigates most.​\n\nDosage and Administration\nStandard dose: 160 mg (four 40 mg capsules) once daily, with or without food. Swallow intact; no crushing. Adjust for CYP2A4 inducers (e.g., rifampin—increase to 240 mg) or strong inhibitors (reduce to 80 mg). Continue until progression/toxicity; no dose interruptions beyond 28 days without reassessment.​\n\nPrecautions and Monitoring\nContraindicated in pregnancy (teratogenic; absolute contraception for men/ partners). Screen for seizure history; CYP2C8/3A4 interactions (e.g., ketoconazole). Baseline LFTs, PSA, testosterone; imaging q8-12 weeks. Elderly (>75) monitor falls.​\nConclusion\nEnzalutamide 40 mg stands as a transformative therapy, empowering prostate cancer patients with prolonged control over aggressive disease through precise AR inhibition. Balancing robust efficacy—evidenced by landmark trials delaying metastasis and death—with proactive side effect management, it enhances survival and daily living. Patients achieve meaningful milestones, from family events to travel, underscoring its role in personalized oncology. Consult oncologists for integration into care plans, ensuring optimal outcomes in this challenging journey.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n\n", "price": 10781.0, "discountamount": 3235.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "doctor", "product", "fatigue", "WhatsApp", "treatment", "schedules", "ENZULAMIDE", "monitoring", "hot flashes", "information", "sterisonline", "hypertension", "sterispharma", "prostate cancer", "Enzalutamide 40mg", "prescribed dosages", "androgen receptors", "cancer cell growth", "Common side effects", "comprehensive guidance" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1527, "imageuri": "https://productimages.withfloats.com/actual/667d2a356c582d228f45a098.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2a356c582d228f45a098.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:40:56.587Z", "updatedon": "2026-03-16T08:18:18.117Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-40mg/1527", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 40", "category": "Oncology", "tags": [ "enzalutamide 40 mg side effects", "enzalutamide 40 mg brands in india", "enzalutamide 40 mg uses in hindi", "enzalutamide 40 mg dosage", "advanced prostate cancer", "prostate cancer", "metastatic castration-resistant prostate cancer", "enzalutamide 40mg tablets", "enzalutamide 40 mg capsule", "enzalutamide 40mg uses", "enzalutamide 40mg dosage", "enzalutamide 40mg price in india", "enzalutamide 40mg composition", "enzalutamide 40mg working mechanism", "enzalutamide 40mg side effects", "enzalutamide 40mg benefits", "enzalutamide 40mg drug information", "enzalutamide 40mg therapy details", "enzalutamide 40mg oral capsule", "enzalutamide 40mg treatment option", "enzalutamide 40mg pharmaceutical uses", "enzalutamide 40mg branded tablets", "enzalutamide 40mg generic medicine", "enzalutamide 40mg manufacturer in india", "what is enzalutamide 40mg used for", "how enzalutamide 40mg works", "is enzalutamide 40mg safe", "enzalutamide 40mg tablet information", "enzalutamide 40mg dosage guidelines" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662ba161f7fe09029cbf518e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 100mg", "description": "TMOZOLMIDE 100\nTemodal 100mg Capsule stands as a cornerstone in oncology, specifically formulated with temozolomide 100mg to combat aggressive brain tumors like glioblastoma multiforme (GBM) and anaplastic astrocytoma. This oral alkylating agent crosses the blood-brain barrier effectively, delivering targeted chemotherapy that disrupts cancer cell DNA replication, halting tumor progression in adults with newly diagnosed or recurrent cases. Patients and caregivers often seek Temodal 100mg for its role in standard-of-care regimens, combining seamlessly with radiotherapy for enhanced survival outcomes in high-grade gliomas.​\n\nManufactured to rigorous standards, Temodal 100mg offers convenient capsule dosing, swallowed whole on an empty stomach to maximize bioavailability. Its proven track record in clinical settings makes it indispensable for neuro-oncology, where timely intervention can extend quality life years amid challenging diagnoses.​\n\nProduct Uses and Mechanism of Action\nTemodal 100mg Capsule primarily treats adult patients with newly diagnosed glioblastoma multiforme alongside radiotherapy, followed by maintenance monotherapy to prevent relapse. It also addresses refractory anaplastic astrocytoma—tumors that progress despite prior therapies—and recurrent malignant gliomas in children over three years, including brainstem glioma and high-grade astrocytoma.​\n\nThe mechanism hinges on temozolomide's rapid conversion to the active metabolite MTIC (5-(3-methyltriazen-1-yl)imidazole-4-carboxamide) at physiological pH, which methylates DNA at O6 and N7 guanine positions. This methylation induces DNA strand breaks during replication, triggering apoptosis in rapidly dividing glioma cells while sparing normal brain tissue to a degree. Unlike intravenous chemotherapies, Temodal 100mg achieves therapeutic CNS concentrations without specialized delivery, ideal for outpatient management.​\n\nIn practice, concomitant phase dosing (75 mg/m² daily with RT for 42 days) transitions to cycles of 150-200 mg/m² on days 1-5 every 28 days, tailored by body surface area and toxicity monitoring. This cyclical approach balances efficacy against cumulative myelosuppression, supporting long-term tumor control.​\n\nKey Benefits of Temodal 100mg Capsule\nTemodal 100mg delivers transformative benefits grounded in landmark trials:\n\nSuperior Survival in GBM: Concomitant temozolomide with RT extends median survival from 12.1 to 14.6 months, with 2-year survival rising from 10% to 26% per pivotal Phase III data.​\n\nMaintenance Therapy Efficacy: Post-RT cycles sustain progression-free survival up to 6-12 months in responders, delaying recurrence in MGMT-methylated tumors.​\n\nConvenient Oral Administration: Eliminates hospital visits, improving compliance for patients undergoing radiotherapy; rapid absorption (peak in 1 hour) ensures consistent exposure.​\n\nBlood-Brain Barrier Penetration: Achieves 30-40% cerebrospinal fluid levels, outperforming many alkylators in CNS malignancies.​\n\nPediatric Applicability: Effective in recurrent pediatric gliomas, with tolerance mirroring adults for ages 3+.​\n\nThese advantages position Temodal 100mg as a first-line essential, particularly for newly diagnosed cases where every month counts toward preserving cognitive function and independence.​\n\nReal-world use extends to off-label scenarios like metastatic melanoma or high-risk meningiomas under specialist oversight, though primary indications remain brain tumors. Its stability in acidic environments enhances reliability during storage and transit.​\n\nSide Effects of Temodal 100mg Capsule\nWhile Temodal 100mg offers life-prolonging potential, its myelotoxic profile demands vigilant hematologic monitoring. Common effects stem from DNA damage in rapidly proliferating bone marrow cells, peaking mid-cycle.​\n\nCommon Side Effects\nHematologic Toxicity: Neutropenia, thrombocytopenia (platelet nadir day 21-28), lymphopenia, and anemia affect 10-20%; febrile neutropenia occurs in vulnerable patients.​\n\nGastrointestinal Issues: Nausea (up to 50%), vomiting, constipation—mitigated by antiemetics like ondansetron taken 30 minutes prior.​\n\nNeurologic Symptoms: Fatigue, headache, ataxia, dizziness, or amnesia-like effects, often transient and RT-attributable.​\n\nOther: Alopecia, anorexia, rash, or elevated liver enzymes resolving post-cycle.​\n\nProphylactic measures like dose delays (if platelets <100 x 10⁹/L or neutrophils <1.5 x 10⁹/L) maintain tolerability; supportive care ensures most complete therapy.​\n\nSerious Side Effects\nRare but critical risks include:\n\nPancytopenia or Aplastic Anemia: Prolonged suppression risking infections or bleeding—mandatory weekly CBCs in early cycles.​\n\nSecondary Malignancies: Myeloid leukemia post-treatment (latency 1-5 years), hepatitis B reactivation.​\n\nOpportunistic Infections: Pneumocystis jirovecii pneumonia (PJP) prophylaxis with TMP-SMX recommended due to grade 3/4 lymphopenia.​\n\nNeurologic Deterioration: Status epilepticus, hemiplegia in advanced disease.​\n\nDiscontinue if non-hematologic CTC grade >2 persists; pregnant women face fetal toxicity—use contraception during and 6 months post-therapy.​\n\nDosage and Administration Guidelines\nInitiate Temodal 100mg at 75 mg/m² daily during RT (up to 49 days), escalating to 150 mg/m² (cycle 1) or 200 mg/m² (subsequent) for 5 days/23 off. Adjust downward for toxicity; hepatic/renal impairment rarely necessitates change unless severe. Capsules (5,20,100,250mg strengths) enable precise BSA-based dosing—e.g., ~100mg capsule for 70kg/m² patients.​\n\nPrecautions and Substitutes\nMonitor pregnancy status; avoid live vaccines. Substitutes include generic temozolomide capsules matching bioequivalence, though Temodal 100mg remains the reference standard. Interactions with valproic acid reduce clearance—increase dose 40% if co-administered.​\n\nConclusion\nTemodal 100mg Capsule empowers patients against glioblastoma's relentless advance, blending potent antineoplastic action with manageable administration for meaningful survival gains. From halting tumor growth via strategic DNA alkylation to fitting seamlessly into multimodal care, it embodies hope amid adversity—always under oncologist guidance to navigate toxicities and optimize outcomes. Embrace informed treatment; lives extend beyond statistics with vigilant care.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 7400.0, "discountamount": 2220.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "body", "types", "drugs", "class", "nausea", "spread", "growth", "surgery", "fatigue", "vomiting", "capsules", "TMOZOLMIDE", "instructions", "Temozolomide", "cancer cells", "brain tumors", "glioblastoma", "unusual symptoms", "potent medication", "other medications", "radiation therapy", "blood cell counts", "healthcare provider", "Common side effects", "comprehensive treatment plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 773, "imageuri": "https://productimages.withfloats.com/actual/662ba164481840e7a7fdadc0.png", "tileimageuri": "https://productimages.withfloats.com/tile/662ba164481840e7a7fdadc0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:43:13.957Z", "updatedon": "2026-03-12T08:07:02.773Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-100mg/773", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 100", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6ae2fef4545d3197abde920c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Faropenem Disperible Tablets 100 mg", "description": "Faropinom 100 DT is a prescription-only antibiotic that provides 100 mg of Faropenem in a dispersible tablet. Faropenem is a penem-type beta-lactam, and doctors use it to treat bacterial infections only when the causative organism is likely to respond to it.\n\nAbout Faropinom 100 DT\n\nThe active ingredient, Faropenem, stops bacteria from building a proper cell wall. The weakened bacteria cannot survive, which helps the body clear a susceptible infection.\n\nThe tablet is meant to be mixed into water before it is taken. This can suit patients who find whole tablets hard to swallow. It should be used strictly as prescribed and according to the leaflet in the pack.\n\nProduct Snapshot\nFeature\tDetails\nBrand\tFaropinom 100 DT\nActive ingredient\tFaropenem 100 mg\nClass\tPenem beta-lactam antibiotic\nForm\tDispersible tablet\nMode of action\tBlocks bacterial cell-wall synthesis\nAvailability\tPrescription-only; subject to Indian regulations\nPurpose\tTreating susceptible bacterial infections on a doctor’s advice\nWhere Faropenem May Be Used\n\nWhether Faropenem is chosen depends on the patient’s condition, the bacteria involved (suspected or confirmed), prevailing treatment guidelines and the approved product information. Infections for which it may be considered include:\n\nRespiratory infections: bacterial infections of the airways or lungs, where the organism is sensitive to Faropenem.\nUrinary infections: bacterial infections of the bladder or wider urinary tract, at a clinician’s discretion.\nEar, nose and throat infections: certain bacterial infections of the ears, throat or sinuses, after examination.\nSkin and soft-tissue infections: selected bacterial skin infections, depending on severity and the organisms responsible.\nOther infections: any further use must follow approved indications, laboratory susceptibility and the treating doctor’s judgement.\n\nPlease note: This antibiotic does not suit every infection. It should never be assumed appropriate for all chest, urinary, skin or genital conditions. Only a qualified healthcare professional can decide whether it is right for a particular patient.\n\nNotable Characteristics\n\n1. Bactericidal action. Faropenem attacks susceptible bacteria by interfering with the machinery that builds their cell walls. How well it works depends on the species and its susceptibility.\n\n2. Activity against some enzyme-producing bacteria. Certain bacteria make beta-lactamase enzymes that disable some beta-lactam antibiotics. Faropenem can work against some of these organisms, but results differ by bacterium and resistance mechanism. It is not a universal answer to resistant infections.\n\n3. Easy-to-prepare format. The tablet is dispersed in water following the pack instructions, which helps those who struggle with swallowing conventional tablets.\n\n4. Focused treatment. Matched to the right infection, it targets the responsible bacteria. Choosing the right antibiotic improves outcomes and limits needless antibiotic exposure.\n\n5. Oral route. When oral therapy is clinically suitable, treatment can proceed without injections. The prescriber decides the route based on the patient’s condition.\n\nHow Faropenem Works\n\nFaropenem attaches to penicillin-binding proteins, which bacteria rely on to assemble and maintain their cell walls. With these proteins blocked, the wall cannot form properly, the bacterial structure weakens and the cell dies. This makes Faropenem bactericidal against susceptible organisms. It does not act on viruses and cannot treat every bacterial infection.\n\nDosing and Administration\n\nThe dose is set by the doctor after considering age, body weight (where relevant), the type and seriousness of the infection, and kidney function.\n\nDose: use only the strength and quantity prescribed.\nFrequency: follow the daily schedule given to you; do not alter it yourself.\nDuration: finish the prescribed course without lengthening or shortening it unless your doctor says so.\nPreparation: disperse the tablet as directed in the leaflet or by your pharmacist.\nMissed dose: check the leaflet or ask a pharmacist. Never double up to make up for a forgotten dose.\n\nNo single dosing plan fits all patients, so a general range should never replace a personal prescription.\n\nPossible Side Effects\n\nAs with other antibiotics, reactions can occur, and they vary from person to person.\n\nMilder effects may include:\n\nNausea or stomach upset\nAbdominal discomfort\nLoose stools or diarrhoea\nRash or itching\nHeadache or dizziness\n\nSpeak to a healthcare professional if these continue, become bothersome or get worse.\n\nGet medical help promptly for:\n\nSerious allergy: swelling of the face, lips, tongue or throat, or trouble breathing is an emergency.\nSevere diarrhoea: persistent, watery or bloody stools may signal a serious antibiotic-related complication.\nSevere skin reaction: widespread rash, blisters or peeling skin needs urgent assessment.\nLiver concerns: yellow skin or eyes, or dark urine, should be checked quickly.\n\nThis list is not exhaustive. Refer to the product information and your doctor for advice specific to you.\n\nPrecautions and Warnings\nAllergies: tell your doctor about any past allergy to Faropenem, penicillins, cephalosporins or other beta-lactams.\nKidney health: report any kidney disease or reduced function, as it can affect suitability and dosing.\nPregnancy and breastfeeding: consult your doctor first if you are pregnant, planning pregnancy or nursing. Use only after a personal benefit–risk assessment.\nOther medicines: share a full list of prescription drugs, over-the-counter products and supplements so interactions can be checked.\nAntibiotic resistance: take Faropenem only for a suitable bacterial infection. Misuse and incorrect dosing fuel resistance.\nMedical history: discuss existing conditions and earlier drug reactions before starting.\nWho Is It For?\n\nFaropinom 100 DT may be considered for patients who need an antibiotic for a susceptible bacterial infection and for whom this dispersible form is suitable. The prescriber decides based on examination, the likely or confirmed organism, individual risk factors and current guidance. It should not be self-started for fever, cough or sore throat without first establishing that an antibiotic is needed.\n\nBuying Faropinom 100 DT in India\n\nBefore purchasing, confirm the brand, strength, manufacturer and the legitimacy of the seller. For safety:\n\nGet a prescription from a registered medical practitioner.\nBuy from a licensed pharmacy or a duly authorised online pharmacy.\nInspect the name, strength, batch number, expiry date and pack condition.\nStore it as the packaging directs.\nAsk the pharmacist if anything is unclear.\n\nPrice and availability: these differ by manufacturer, pack size, pharmacy and location. Confirm current details with a licensed seller rather than an unverified figure.\n\nFrequently Asked Questions\n\n1. What is Faropinom 100 DT prescribed for?\nIt contains Faropenem 100 mg and is used for certain bacterial infections when the organism is susceptible and the medicine is clinically suitable.\n\n2. Is it an antibiotic?\nYes. Faropenem is a penem-class beta-lactam that disrupts bacterial cell-wall formation.\n\n3. What is the active ingredient?\nFaropenem 100 mg. Check the pack for full composition details.\n\n4. Will it cure a common cold?\nNo. Colds are viral, and antibiotics do not act on viruses.\n\n5. How do I take it?\nExactly as prescribed. Prepare the dispersible tablet in water as described in the leaflet or by your pharmacist.\n\n6. What is the right dose?\nIt depends on the infection, your age, kidney function and other individual factors. Follow your doctor’s prescription.\n\n7. How long is the course?\nThe duration depends on the infection and your response. Complete the course unless your doctor changes it.\n\n8. What side effects can occur?\nStomach upset, nausea, diarrhoea, headache and skin reactions are possible. Seek advice if they persist or become severe.\n\n9. Can it cause diarrhoea?\nYes, as antibiotics can. Contact a healthcare professional quickly if it is severe, long-lasting or bloody.\n\n10. Can I stop once I feel better?\nDo not stop or alter treatment on your own. Talk to your doctor about side effects or if you think treatment is no longer needed.\n\n11. Is it safe in pregnancy?\nA doctor must assess this individually. Do not use it in pregnancy without medical advice.\n\n12. Can I use it while breastfeeding?\nAsk your doctor first. The decision rests on available safety data and your circumstances.\n\n13. Can people with kidney problems take it?\nThey should tell their doctor beforehand, who will decide on suitability and any adjustment.\n\n14. Is Faropenem a penicillin?\nNo, it is a penem. Both are beta-lactams, so discuss any antibiotic allergy history with your prescriber.\n\n15. Is alcohol allowed during treatment?\nAsk your doctor or pharmacist, especially if you have other conditions or take other medicines. Avoid alcohol if it worsens symptoms.\n\n16. What if I miss a dose?\nConsult the leaflet or your pharmacist. Do not take a double dose unless a professional tells you to.\n\n17. Does it work on resistant bacteria?\nIt may act on certain bacteria that resist some other antibiotics, but this depends on the organism and resistance mechanism. Medical assessment is essential.\n\n18. Can it be used for any infection?\nNo. It is for suitable bacterial infections only, chosen through clinical assessment and, where needed, lab testing.\n\n19. What does it cost in India?\nConfirm the current price with a licensed pharmacy, as it varies by pack size, maker and location.\n\n20. Where can I buy it?\nEnquire at a licensed local or authorised online pharmacy. A valid prescription may be required under applicable rules.\n\nConclusion\n\nFaropinom 100 DT is a dispersible Faropenem 100 mg antibiotic for selected bacterial infections, to be used under a qualified healthcare professional’s guidance. It works by disrupting bacterial cell-wall formation, and the dispersible form offers an alternative for patients who find standard tablets difficult.\n\nResponsible use depends on accurate diagnosis, the right antibiotic choice, sticking to the prescribed regimen and watching for side effects. Always consult a healthcare professional before starting, stopping or changing antibiotic treatment.", "price": 590.0, "discountamount": 177.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2506, "imageuri": "https://productimages.withfloats.com/actual/6ae2fef754689b1ff0217bf5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae2fef754689b1ff0217bf5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-29T08:08:20.798Z", "updatedon": "2026-10-29T08:08:20.798Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//faropenem-disperible-tablets-100-mg/2506", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Faropinom 100 DT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad73c502f1fbe0284e2dcb5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ketorolac Tromethamine Ophthalmic Solution", "description": "CIPVISION KEYPROFEN 0.5 is an ophthalmic formulation containing Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory drug (NSAID) used in specific eye-care situations. It works by reducing the production of prostaglandins, chemical substances that contribute to pain and inflammation. This action may help manage certain inflammatory eye symptoms when the medicine is prescribed for an appropriate condition.\n\nCIPVISION KEYPROFEN 0.5 is intended for topical application to the eyes under the supervision of a qualified healthcare professional. Its suitability depends on the patient's symptoms, clinical diagnosis, and the approved product information.\n\nFor pharmacies, medical distributors, healthcare professionals, and pharmaceutical product catalogues, CIPVISION KEYPROFEN 0.5 represents an ophthalmic product containing a recognised anti-inflammatory ingredient. Appropriate product information helps users understand its intended role, administration requirements, and important precautions.\nComposition of CIPVISION KEYPROFEN 0.5\nThe stated active ingredient in CIPVISION KEYPROFEN 0.5 is:\n\nKetorolac Tromethamine 0.5% w/v: This medicine belongs to the NSAID class. It inhibits cyclooxygenase enzymes involved in the production of prostaglandins, helping reduce inflammatory activity and associated discomfort in suitable ophthalmic conditions.\n\nThe complete formulation, inactive ingredients, pack size, and approved therapeutic indications should be verified using the product packaging and official prescribing information.\nKey Features of CIPVISION KEYPROFEN 0.5 Eye Drops\nCIPVISION KEYPROFEN 0.5 has several important characteristics relevant to ophthalmic care:\n- NSAID-based formulation: Contains Ketorolac Tromethamine, a non-steroidal anti-inflammatory medicine.\n- Inflammation control: Helps manage inflammation in specific eye conditions when prescribed appropriately.\n- Prostaglandin reduction: Acts by inhibiting enzymes involved in the formation of inflammatory mediators.\n- Topical eye application: Designed for administration directly into the eye according to prescribed directions.\n- Clinically guided use: Requires an appropriate diagnosis and advice from an eye-care professional.\nThe potential role of this medicine depends on the underlying eye condition, the approved product indications, and the patient's individual health requirements.\nWhat Is CIPVISION KEYPROFEN 0.5 Used For?\nCIPVISION KEYPROFEN 0.5 may be prescribed for selected eye conditions in which reducing inflammation, itching, or pain is clinically appropriate. The precise indication should be confirmed from the approved product information.\n1. Management of Selected Inflammatory Eye Conditions\nInflammation of the eye may cause redness, irritation, watering, and discomfort. Ketorolac Tromethamine reduces the production of prostaglandins involved in the inflammatory response. An ophthalmologist can determine whether this medicine is suitable after assessing the cause of the symptoms.\n2. Relief of Certain Types of Eye Discomfort\nKetorolac Tromethamine ophthalmic preparations may help relieve ocular pain in approved clinical situations. Some formulations are also indicated for itching associated with seasonal allergic conjunctivitis. These uses depend on the specific product's approved labelling.\n\nPersistent eye pain, redness, or irritation should not be treated through self-medication because these symptoms can arise from infections, injuries, or other conditions requiring different treatment.\n3. Eye Care Following Certain Surgical Procedures\nSome Ketorolac Tromethamine ophthalmic products are used to manage pain and inflammation associated with eye surgery, including cataract procedures. Postoperative treatment must follow the ophthalmologist's instructions because the appropriate medicine, dosage, and duration depend on the procedure and the patient's recovery.\n\nAlways verify whether CIPVISION KEYPROFEN 0.5 is approved for the intended postoperative use before including a specific surgical indication in product information.\nHow Does CIPVISION KEYPROFEN 0.5 Work?\nKetorolac Tromethamine belongs to the non-steroidal anti-inflammatory drug category. Its action involves inhibiting cyclooxygenase (COX) enzymes, which help produce prostaglandins.\n\nProstaglandins participate in inflammatory processes and pain signalling. By reducing their production, Ketorolac Tromethamine can help control inflammation and associated discomfort in certain eye conditions.\n\nUnlike corticosteroids, Ketorolac Tromethamine is a non-steroidal anti-inflammatory medicine. However, it is not appropriate for every eye complaint. It does not treat all causes of eye redness or pain, and suspected infections may require a different treatment approach.\nPotential Benefits of CIPVISION KEYPROFEN 0.5\nWhen prescribed for an appropriate indication, CIPVISION KEYPROFEN 0.5 may offer the following benefits:\n- Anti-inflammatory action: Helps reduce inflammatory activity in selected ophthalmic conditions.\n- Management of eye pain: May relieve pain in specific clinical situations covered by the relevant product indication.\n- Non-steroidal treatment option: Provides an alternative mechanism to corticosteroid-based medicines for appropriate cases.\n- Local administration: Allows the active ingredient to be delivered directly to the eye.\n- Support for ophthalmic treatment: May be included in a treatment plan developed by an eye-care professional.\nThe response to treatment varies according to the diagnosis, severity of the condition, individual health factors, and adherence to the prescribed instructions. The product should not be considered a universal treatment for eye pain or inflammation.\nHow to Use CIPVISION KEYPROFEN 0.5 Eye Drops\nUse CIPVISION KEYPROFEN 0.5 only according to your ophthalmologist's instructions and the product leaflet.\n1. Clean your hands: Wash and dry your hands before handling the eye-drop bottle.\n2. Check the bottle: Confirm the product name, expiry date, and administration instructions before use.\n3. Prevent contamination: Keep the dropper tip away from your eyes, eyelids, fingers, and other surfaces.\n4. Follow the prescribed dosage: Use only the recommended number of drops and the prescribed frequency.\n5. Use other eye medicines carefully: Ask your healthcare professional how much time to leave between different ophthalmic preparations.\n6. Avoid prolonged use: Do not continue treatment longer than recommended, as extended NSAID use may increase the risk of eye complications.\n7. Follow storage instructions: Store the medicine as directed on its packaging and observe any instructions concerning use after opening.\n8. Do not share the bottle: Sharing eye drops can increase the risk of contamination.\n9. Attend follow-up appointments: Follow your ophthalmologist's advice, particularly when using the medicine after eye surgery.\nIf you miss a dose, follow the instructions in the product leaflet or consult your healthcare professional. Do not double the next dose to compensate for a missed application.\nPrecautions and Safety Information\nAlthough Ketorolac Tromethamine eye drops can be useful in appropriate clinical settings, they may cause side effects and require additional caution in certain patients.\nPossible Side Effects\nSome people may experience temporary burning, stinging, irritation, or discomfort after applying the drops. Ophthalmic NSAIDs can also delay healing and, in susceptible individuals, increase the risk of corneal complications. Rare cases of serious corneal damage have been reported.\n\nContact your ophthalmologist if symptoms persist or worsen. Seek urgent medical assessment if you experience severe eye pain, significant changes in vision, marked redness, or other serious symptoms.\nImportant Precautions\n- Corneal conditions: Tell your doctor if you have corneal disease, a damaged eye surface, or delayed healing.\n- Dry eyes: Inform your healthcare professional if you have severe dry eye symptoms or another condition affecting the eye surface.\n- Allergies: Disclose any previous allergic reaction to Ketorolac, aspirin, or other NSAIDs.\n- Bleeding risks: Discuss any bleeding disorder or medicine that may increase bleeding risk.\n- Eye surgery: Follow your surgeon's instructions, as postoperative use requires appropriate monitoring.\n- Pregnancy and breastfeeding: Consult your doctor before using the medicine during pregnancy or while breastfeeding.\n- Other medicines: Inform your healthcare professional about all medicines and eye preparations you currently use.\nCIPVISION KEYPROFEN 0.5 is intended for ophthalmic use only. Keep it out of children's reach and never use it beyond the labelled expiry date.\nWhy Consider CIPVISION KEYPROFEN 0.5 for Pharmaceutical Product Portfolios?\nCIPVISION KEYPROFEN 0.5 combines a distinct pharmaceutical brand identity with Ketorolac Tromethamine 0.5% ophthalmic solution. The formulation may be relevant to product catalogues serving pharmacies, medical distributors, and healthcare professionals involved in ophthalmic care.\n\nClear product information supports responsible pharmaceutical communication by explaining the active ingredient, its mechanism of action, appropriate clinical applications, and safety considerations.\n\nFor accurate product representation, always verify the approved strength, indications, contraindications, dosage, storage requirements, and instructions against the official packaging and prescribing information.\nConclusion\nCIPVISION KEYPROFEN 0.5 Eye Drops contains Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory ingredient used in selected ophthalmic conditions. By inhibiting prostaglandin production, it helps manage inflammation and may relieve pain in specific approved clinical settings.\n\nCorrect administration, appropriate patient selection, and awareness of potential side effects are essential for responsible use. Consult a qualified eye-care professional for treatment guidance and refer to the approved product information for complete details.\nFrequently Asked Questions (FAQs)\n1. What is CIPVISION KEYPROFEN 0.5?\nCIPVISION KEYPROFEN 0.5 is an ophthalmic solution containing Ketorolac Tromethamine 0.5% w/v, according to the composition provided. It is intended for specific eye-care applications under professional guidance.\n2. What is CIPVISION KEYPROFEN 0.5 used for?\nKetorolac Tromethamine ophthalmic preparations may be prescribed for certain inflammatory eye conditions, itching associated with seasonal allergic conjunctivitis, or pain and inflammation following specific eye procedures. The approved uses of CIPVISION KEYPROFEN 0.5 must be confirmed from its official product information.\n3. How does Ketorolac Tromethamine work in the eyes?\nKetorolac Tromethamine inhibits cyclooxygenase enzymes involved in prostaglandin production. This helps reduce inflammatory activity and associated pain in appropriate ophthalmic conditions.\n4. Can CIPVISION KEYPROFEN 0.5 be used without a prescription?\nUse this medicine only under appropriate medical guidance. An eye-care professional should determine whether it is suitable, particularly because NSAID eye drops can affect healing and may cause complications in susceptible patients.\n5. What precautions should be taken while using CIPVISION KEYPROFEN 0.5?\nAvoid contaminating the dropper tip, follow the prescribed dosage, and do not use the drops for longer than recommended. Inform your doctor about corneal problems, allergies to NSAIDs, bleeding disorders, and other medicines you use.\n6. How should CIPVISION KEYPROFEN 0.5 be stored?\nFollow the storage instructions on the product packaging. Keep the container closed as directed, protect it from unsuitable storage conditions, and observe any instructions concerning disposal after opening.\n\n\n", "price": 80.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2503, "imageuri": "https://productimages.withfloats.com/actual/6ad73c52dc6a6c6c9945f376.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad73c52dc6a6c6c9945f376.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:02:56.893Z", "updatedon": "2026-10-20T10:02:56.893Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ophthalmic-solution/2503", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION KEYPROFEN 0.5", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad738866e5950566f21f588", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ofloxacin & Dexamethasoneone Sodium Phosphate Eye/Ear Drops", "description": "CIPVISION ONLYAX DEXA Eye/Ear Drops is a pharmaceutical formulation containing Ofloxacin and Dexamethasone Sodium Phosphate. These ingredients perform complementary roles: Ofloxacin helps control infections caused by susceptible bacteria, while Dexamethasone Sodium Phosphate helps reduce inflammation. The combination may be prescribed for selected eye or ear conditions when both antibacterial treatment and inflammation control are clinically appropriate.\n\nIntended for ophthalmic and otic applications, CIPVISION ONLYAX DEXA should be used according to a qualified healthcare professional's instructions. The suitability of this formulation depends on the patient's diagnosis, medical history, and the approved product information.\n\nWith its defined composition and distinct brand identity, CIPVISION ONLYAX DEXA is a pharmaceutical product option for healthcare professionals, pharmacies, and medical distributors.\n\nComposition of CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nCIPVISION ONLYAX DEXA contains two active pharmaceutical ingredients:\n\nOfloxacin: A fluoroquinolone antibiotic that works by interfering with bacterial enzymes required for DNA replication and repair. This action helps inhibit the growth of susceptible bacteria.\n\nDexamethasone Sodium Phosphate: A corticosteroid that suppresses inflammatory responses and helps reduce symptoms such as redness, swelling, and discomfort when steroid treatment is appropriate.\n\nThe exact strength, approved indications, and recommended dosage should always be checked on the product packaging and prescribing information.\n\nKey Features of CIPVISION ONLYAX DEXA\n\nThe formulation combines antibacterial and anti-inflammatory properties in one topical product.\n\nDual-ingredient formulation: Combines an antibiotic with a corticosteroid.\n\nAntibacterial action: Ofloxacin targets susceptible bacteria when used for an appropriate indication.\n\nInflammation control: Dexamethasone Sodium Phosphate helps manage inflammatory symptoms.\n\nTopical application: Intended for eye or ear use according to the approved product labelling.\n\nProfessional supervision: Requires appropriate clinical assessment and guidance for safe use.\n\nThe suitability of these features depends on the diagnosed condition and whether both ingredients are necessary for treatment.\n\nWhat Is CIPVISION ONLYAX DEXA Used For?\n\nCIPVISION ONLYAX DEXA may be prescribed for certain bacterial eye or ear conditions accompanied by inflammation. A healthcare professional must determine whether this combination is appropriate for the specific diagnosis.\n\nOphthalmic Applications\n\nWhen indicated by the approved product label, an Ofloxacin and Dexamethasone formulation may be used for selected bacterial eye conditions associated with inflammation.\n\nOfloxacin helps address susceptible bacterial pathogens, while Dexamethasone Sodium Phosphate helps control the inflammatory response. However, eye redness, watering, itching, and pain can result from allergies, viral infections, fungal infections, or other disorders. These conditions may require different treatments.\n\nA proper eye examination is important before using antibiotic-corticosteroid drops.\n\nOtic Applications\n\nFor selected ear conditions, an appropriate antibiotic and corticosteroid combination may be prescribed when bacterial infection and inflammation occur together.\n\nSymptoms such as ear pain, discharge, swelling, and itching can have different causes. The choice of treatment depends on the site of infection, the condition of the eardrum, and the product's approved indications.\n\nUse CIPVISION ONLYAX DEXA in the ear only when the prescribing information permits it and a healthcare professional recommends its use.\n\nHow Does CIPVISION ONLYAX DEXA Work?\n\nThe two active ingredients act through different mechanisms.\n\nOfloxacin: This antibiotic inhibits bacterial enzymes called DNA gyrase and topoisomerase IV. These enzymes are essential for bacterial DNA replication and repair. Interfering with these processes helps prevent susceptible bacteria from multiplying.\n\nDexamethasone Sodium Phosphate: This corticosteroid reduces inflammatory activity in affected tissues. It helps control inflammation and associated symptoms when corticosteroid treatment is medically appropriate.\n\nTogether, these ingredients provide antibacterial and anti-inflammatory effects in selected conditions. However, corticosteroids may mask signs of infection or worsen certain untreated infections. Therefore, this combination should only be used for an appropriate diagnosis under medical supervision.\n\nPotential Benefits of CIPVISION ONLYAX DEXA\n\nThe potential benefits depend on the patient's condition and the clinical suitability of the formulation.\n\nCombined treatment approach: Offers an antibiotic and an anti-inflammatory ingredient in one formulation.\n\nTargeted antibacterial activity: Ofloxacin acts against susceptible bacteria.\n\nInflammation management: Dexamethasone Sodium Phosphate helps reduce inflammation.\n\nLocal administration: Drops allow topical application when suitable for the diagnosed condition.\n\nSupport for prescribed treatment: May be included in a healthcare professional's treatment plan for selected eye or ear conditions.\n\nThis product is not suitable for every infection. Its effectiveness depends on the cause of the condition, bacterial susceptibility, correct administration, and adherence to the prescribed treatment.\n\nHow to Use CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nUse CIPVISION ONLYAX DEXA according to your doctor's instructions and the product label.\n\nWash your hands: Clean your hands before handling the bottle or administering the drops.\n\nCheck the product: Confirm the product name, expiry date, and instructions before use.\n\nAvoid contamination: Do not allow the dropper tip to touch your eye, ear, fingers, or other surfaces.\n\nFollow the prescribed dose: Use only the number of drops and the frequency recommended by your healthcare professional.\n\nComplete the prescribed course: Do not stop, extend, or repeat treatment without medical advice.\n\nAvoid sharing: Never share the bottle with another person, as this can spread infection.\n\nStore correctly: Follow the storage and after-opening instructions printed on the packaging.\n\nFor eye administration, ask your healthcare professional about contact lens precautions. For ear administration, seek advice before use if you have had ear surgery, have ear tubes, or may have a perforated eardrum.\n\nPrecautions and Safety Information\n\nCIPVISION ONLYAX DEXA should be used only when clinically indicated. Its antibiotic and corticosteroid components may not be appropriate for every patient or type of infection.\n\nProlonged use: Extended or inappropriate corticosteroid use may increase eye pressure, contribute to glaucoma or cataracts, and delay tissue healing.\n\nInfection risks: Corticosteroids may mask symptoms or worsen certain viral, fungal, or untreated infections.\n\nAllergies: Inform your healthcare professional about any previous reaction to Ofloxacin, Dexamethasone, or related ingredients.\n\nExisting conditions: Disclose any history of glaucoma, eye disease, ear problems, or ear surgery before treatment.\n\nOther medicines: Tell your doctor about other prescription medicines and eye or ear preparations you are using.\n\nPregnancy and breastfeeding: Seek medical advice before using the product during pregnancy or while breastfeeding.\n\nWorsening symptoms: Obtain prompt medical assessment if symptoms persist, worsen, or return after treatment.\n\nSeek urgent medical attention for severe eye pain, sudden changes in vision, significant hearing changes, or other serious symptoms.\n\nDo not use the product after its expiry date. Follow the packaging instructions for storage and disposal after opening.\n\nWhy Is CIPVISION ONLYAX DEXA Relevant to Pharmaceutical Product Portfolios?\n\nCIPVISION ONLYAX DEXA combines two established pharmaceutical ingredients in a topical formulation intended for selected conditions involving bacterial infection and inflammation. Its defined composition and identifiable brand make it relevant to pharmaceutical catalogues and product information resources.\n\nFor pharmacies, distributors, healthcare professionals, and pharmaceutical websites, clear product information helps communicate the formulation's intended use, precautions, and administration requirements. Accurate product descriptions should always reflect the approved label rather than imply that the formulation is suitable for every eye or ear complaint.\n\nConclusion\n\nCIPVISION ONLYAX DEXA Eye/Ear Drops contains Ofloxacin and Dexamethasone Sodium Phosphate, combining antibacterial activity with anti-inflammatory action. It may be prescribed for selected eye or ear conditions when both components are clinically appropriate.\n\nUnderstanding the composition, intended applications, administration precautions, and potential risks supports responsible use. Always consult a qualified healthcare professional and refer to the approved product packaging for the exact strength, indications, contraindications, and directions for use.\n\nFrequently Asked Questions (FAQs)\n\n1. What is CIPVISION ONLYAX DEXA Eye/Ear Drops?\n\nCIPVISION ONLYAX DEXA is a pharmaceutical formulation containing Ofloxacin, an antibiotic, and Dexamethasone Sodium Phosphate, a corticosteroid. It is intended for selected conditions as directed by a healthcare professional.\n\n2. What is the composition of CIPVISION ONLYAX DEXA?\n\nThe stated active ingredients are Ofloxacin and Dexamethasone Sodium Phosphate. Refer to the product packaging to confirm their exact strengths and the approved formulation details.\n\n3. What is CIPVISION ONLYAX DEXA used for?\n\nIt may be prescribed for certain bacterial eye or ear conditions associated with inflammation when an antibiotic-corticosteroid combination is appropriate.\n\n4. Can CIPVISION ONLYAX DEXA be used without medical advice?\n\nNo. Medical guidance is important because the corticosteroid component may worsen certain infections or be unsuitable for particular eye and ear conditions.\n\n5. How should CIPVISION ONLYAX DEXA be stored?\n\nFollow the storage instructions printed on the product packaging. Keep the bottle tightly closed as directed, protect it from unsuitable storage conditions, and keep it out of children's reach.\n\n6. Can CIPVISION ONLYAX DEXA be used for every type of eye or ear infection?\n\nNo. Different infections and inflammatory conditions require different treatments. A healthcare professional should identify the cause of the symptoms and confirm whether this formulation is appropriate.", "price": 50.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2502, "imageuri": "https://productimages.withfloats.com/actual/6ad73887063777c0e22d5809.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad73887063777c0e22d5809.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T09:46:46.02Z", "updatedon": "2026-10-20T09:46:46.02Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ofloxacin-dexamethasoneone-sodium-phosphate-eye-ear-drops/2502", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION ONLYAX DEXA", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
transformative effects?

Still searching for
transformative effects?

Chat with us